Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002478025 | SCV002781404 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2022-04-08 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001795631 | SCV003821788 | uncertain significance | not provided | 2020-12-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003331204 | SCV004038639 | uncertain significance | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001795631 | SCV002034907 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001795631 | SCV002036842 | uncertain significance | not provided | no assertion criteria provided | clinical testing |